Effectiveness of ANI and SPI as a measure of pain in patients undergoing cystoscopic procedure under remifentanil infusio

Not Applicable

Recruiting

• Conditions: Diseases of the genitourinary system

• Registration Number: KCT0008687
• Lead Sponsor: Inje University Sanggye Paik Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 August 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Adult patients (> 18 years) undergoing cystoscopic procedure under monitored anesthetic care (remifentanil infusion)

Exclusion Criteria

- ASA physical status class 5
- Morbid obesity ( BMI =, >35)
- Severe valvular heart disease
- Arrhythmia such as atrial fibrillation
- History of cardiac transplantation, Patients with cardiac pacemaker
- CNS disorder, autonomic disease
- Cognitive disorder including deliruim, dementia
- Patients taking alpha-2 agonist, beta blockers, or antiarrhythmics
- Patients chronically taking sedative hypnotics and narcotic analgesics
- Patients who underwent nerve block for pain control
- emergency surgery
- Patients with mean BP below 60 mmHg and heart rate below 45 bpm and above 120 bpm on the morning of surgery
- in case that investigators judge that it is inappropriate to participate in this study

Study & Design

• Study Type: Observational Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ANI value, SPI value, pain scores (NRS)

Secondary Outcome Measures

Name	Time	Method
BP, HR, SpO2, RR